Company Filing History:
Years Active: 2025
Title: Innovations of Jakob Richter in Pulmonary Drug Delivery
Introduction
Jakob Richter is an accomplished inventor based in Munich, Germany. He has made significant contributions to the field of pulmonary drug delivery through his innovative methods and systems. His work focuses on enhancing the efficacy of aerosol-based drug delivery systems, which are crucial for treating respiratory conditions.
Latest Patents
Jakob Richter holds a patent for a "Method for assessing the efficacy of an aerosol for pulmonary drug delivery as well as inhaler device, orally inhaled and/or nasal drug product and drug/device combination product." This invention relates to systems and methods for evaluating the effectiveness of aerosols generated by inhaler devices. The patent outlines a comprehensive approach that includes providing a computational lung model and a particle transport and deposition model. By computing the spatial particle deposition distribution and efficacy values, the method allows for an automatic assessment of the aerosol's effectiveness in delivering medication to the lungs.
Career Highlights
Jakob Richter is associated with Ebenbuild GmbH, where he continues to develop innovative solutions in the field of drug delivery. His expertise in computational modeling and aerosol technology has positioned him as a key figure in advancing pulmonary therapies. With a focus on practical applications, his work aims to improve patient outcomes in respiratory health.
Collaborations
Jakob collaborates with notable colleagues such as Jonas Biehler and Karl-Robert Klaus Wichmann. Their combined expertise fosters a dynamic environment for innovation and research in the field of inhalation therapies.
Conclusion
Jakob Richter's contributions to pulmonary drug delivery through his patented methods and collaborative efforts highlight the importance of innovation in healthcare. His work continues to pave the way for advancements in respiratory treatment options.